Technology Networks
| ||
| Permissions | ||
|
Permission to use, copy and distribute documents presented on this World Wide Web site and related graphics is not granted without prior written permission of Technology Networks Ltd
To obtain this permission contact:
In cases where permission is granted, it is done so under the provision that the above copyright notice and this permission notice appear in all copies. All other rights are reserved. |
Fall in Deaths Following Withdrawal of Pain Killer
Reduction in deaths after withdrawn of pain-relief drug co-proxamol in UK. Interfacing Medicinal Chemistry with Structural Bioinformatics The observed aaRS-specific stability differences between key riboswitch structural elements could potentially be targeted to effect ligand-specificity in future drug discovery efforts. Revolutionary New Cancer Targeting Technology Described in Nature Medicine Immunocore scientists manage to overcome cancer problem by boosting the ability of cancer-specific TCRs. Anti-HIV Drug Use During Pregnancy Does Not Affect Infant Size, Birth Weight NIH study indicates drug safe during pregnancy, but infants smaller at first birthday. Prosonix Demonstrates Improved Delivery and Co-localization of Respiratory Medicines New review published in European Respiratory Disease(ERD). Design, Synthesis and Activity Study of Aminopeptidase N Targeted AHPA Derivatives APN was shown to be involved in the degradation of extracellular matrix in tumor invasion and may serve as a target receptor for drug delivery into tumors and also contribute to angiogenesis. Researchers Turn Big Data Problems into Advanced Biology and Drug Discoveries University of Illinois at Chicago and The Genome Analysis Centre in Norwich, UK leverage SGI(R) UV(TM) to accelerate drug discovery and complex problem analysis. New Research on Zebrafish Brings a Cure for Hearing Loss Closer Zebrafish to discover drugs that may lead to the restoration of hearing. Enabling Large-Scale Design, Synthesis and Validation of Small Molecule Protein-Protein Antagonists With the number of new drug applications (NDA) on the decline, a new approach that stops our dependence from old compounds, and utilizes the vast information available on protein interactions and structure, is desperately needed. Preclinical Predictors of Anticancer Drug Efficacy: Critical Assessment with Emphasis on Nanomolar Potency This article looks at prediction of cancer drug efficacy in its ultimate user, the human patient and reviews current knowledge followed by illustrative examples that, in the absence of definitive data, provide an empirical perspective. 
| |
